-
Behind the 700 million people infected with helicobacter pylori, the 10 billion acid suppressant market is facing reshuffle
Behind the 700 million people infected with helicobacter pylori, the 10 billion acid suppressant market is facing reshuffle
2023-06-14 rix68722912
-
Introduction to the innovative anti-HIV drug Albuvirtide - 1417179-66-8
Introduction to the innovative anti-HIV drug Albuvirtide - 1417179-66-8
2023-06-14 rix68722912
-
A week of new drug development highlights
A week of new drug development highlights
2023-06-13 rix68722912
-
A week of new drug development highlights
In the field of anti-infective drugs, Jiangxi Jemincare Group and Shanghai Jemincare Pharmaceutical Company discovered new antifungal compounds. In the field of endocrine drugs, Gilead Sciences and LG
2023-06-13 hanhong
-
Hanhong Technology will participate in ChemEurope 2023
Hanhong Technology will participate in ChemEurope 2023
2023-06-13 hanhong
-
Hanhong Technology CPHI 2023 booth information
CPHI & PMEC China will be held in Shanghai New International Expo Center on June 19-21, 2023, Hanhong Technology booth number: N1C62
2023-06-13 hanhong
-
Hanhong Technology successfully developed a new production process of L-serine
Hanhong Technology successfully developed a new production process of L-serine
2023-06-13 hanhong
-
Shanghai Hanhong L-2-aminobutyric acid project put into operation
Shanghai Hanhong L-2-aminobutyric acid project put into operation. L-2-aminobutyric acid (L-2-AMinobutyric acid) is a natural amino acid that inhibits the transmission of human nerve information. It i
2023-06-13 hanhong